Your browser doesn't support javascript.
loading
Sodium glucose cotransporter-2-inhibitor dapagliflozin improves nonalcoholic fatty liver disease by ameliorating dipeptidyl-peptidase-4 protein expression in diabetic mice.
Zhao, Dong-Ming; Li, Cheng-Qiang; Sun, Yu-Man; Fan, Jin-Yang; Wu, Nan; Sun, Ya-Nan; Sun, Xin-Yi.
Afiliação
  • Zhao DM; Department of General Medicine, Affiliated Hospital of Beihua University, Chuanying, Jilin, China.
  • Li CQ; Department of General Medicine, Affiliated Hospital of Beihua University, Chuanying, Jilin, China.
  • Sun YM; Department of Endocrinology, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, China.
  • Fan JY; Department of General Medicine, Affiliated Hospital of Beihua University, Chuanying, Jilin, China.
  • Wu N; Department of General Medicine, Affiliated Hospital of Beihua University, Chuanying, Jilin, China.
  • Sun YN; Department of General Medicine, Affiliated Hospital of Beihua University, Chuanying, Jilin, China.
  • Sun XY; Department of General Medicine, Affiliated Hospital of Beihua University, Chuanying, Jilin, China.
Endokrynol Pol ; 74(2): 190-196, 2023.
Article em En | MEDLINE | ID: mdl-37039492
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article